Agile Therapeutics Provides Clinical Update on Twirla and Status of Pipeline Evaluation
Stock Information for Agile Therapeutics Inc.
Please wait while we load your information from QuoteMedia.
More Recent News About Agile Therapeutics Inc.
Agile Therapeutics Reports Fourth Quarter & Full Year 2022 Financial Results and Provides Corporate Update
Agile Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on Wednesday, March 22, 2023
Agile Therapeutics Announces Distribution of Series C Preferred Stock to its Holders of Common Stock